Sam – Page 327 – biolegacy

<b>OZMOSI</b> Launches A Global Clinical Trials Database To Transform Drug Development Forecasting

Post author:Sam
Post published:September 10, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

The Search is Over: Struggling Teva Finally Gets a New CEO

Post author:Sam
Post published:September 10, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-teva-kare-schultz.jpg" NAME"The Search is Over: Struggling Teva Finally Gets a New CEO" ALT"The Search is Over: Struggling Teva Finally Gets a New CEO"September 11, 2017By Alex Keown, BioSpace.com Breaking…

ImmusanT, Inc. Presents Data From Multiple Studies Supporting Continued Development Of Nexvax2

Post author:Sam
Post published:September 10, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

Why This Bay Area Biotech Could be a Cash Cow for Investors

Post author:Sam
Post published:September 10, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"Why This Bay Area Biotech Could be a Cash Cow for Investors" ALT"Why This Bay Area Biotech Could be a Cash Cow for Investors"September 11, 2017By Mark Terry,…

Iovance Biotherapeutics Partners With TrakCel For Personalized Patient Product Management

Post author:Sam
Post published:September 10, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

Otsuka Loses Again in Challenge to FDA Green Light for Competing Drug

Post author:Sam
Post published:September 8, 2017
Post category:Drug Industry Daily

A federal appeals court rejected a challenge by Otsuka Pharmaceuticals to the FDA’s decision to deny exclusive marketing rights to Otsuka’s antipsychotic injectable Abilify Maintena vis-a-vis a competing antipsychotic drug.…

FDA Researchers Seek Ways to Avoid Shelf-Life Chemical Reactions in Complex Proteins

Post author:Sam
Post published:September 8, 2017
Post category:Drug Industry Daily

FDA researchers are developing methods to examine and control chemical reactions that can impact the shelf-life, quality, safety and efficacy of protein-based biopharmaceuticals. Source: Drug Industry Daily

ICH Finalizes Q&A Doc on Justifying Drug Starting Materials

Post author:Sam
Post published:September 8, 2017
Post category:Drug Industry Daily

The ICH has finalized a Q&A document clarifying its advice on the selection and justification of starting materials used in drug manufacturing. Source: Drug Industry Daily

FDA Advisory Committee Recommends Warning for Gadolinium MRI Agents

Post author:Sam
Post published:September 8, 2017
Post category:Drug Industry Daily

An FDA advisory committee voted 13-to-1 in favor of adding a warning about the risk of gadolinium retention to prescribing information for gadolinium-based contrast agents used in MRI scans. Source:…

FDA Berates Pfizer Unit for EpiPen Misfires During 'Life-Threatening Emergencies'

Post author:Sam
Post published:September 7, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"FDA Berates Pfizer Unit for EpiPen Misfires During 'Life-Threatening Emergencies'" ALT"FDA Berates Pfizer Unit for EpiPen Misfires During 'Life-Threatening Emergencies'"September 8, 2017By Alex Keown, BioSpace... Source: BioSpace